Ketamine & Related Compounds International Journal Club
32. At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial

32. At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial

by | Jul 26, 2022 | Uncategorized

At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial Presented on Tuesday 26th July 2022 | 12.30pm EST | 5.30pm UK Thomas D Hull,...